XM无法为美国居民提供服务。
T
T

ThermoFisher


市场新闻

U.S. Coca-Cola, Nextera Energy Partners, ServiceNow

U.S. RESEARCH ROUNDUP-Coca-Cola, Nextera Energy Partners, ServiceNow Oct 24 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies including Coca-Cola, Nextera Energy Partners, and ServiceNow on Thursday. HIGHLIGHTS * Avery Dennison Corp AVY.N : JP Morgan cuts to neutral from overweight * Coca-Cola Co KO.N : JP Morgan cuts target price to $75 from $78 * Nextera Energy Partners LP NEP.N : JP Morgan raises to neutral from underweight *
A
A
A
B
C
D
D
E
E
N
R
C
L
T
E
E
I
S
T
A
A
E
E
G
H
L
R

U.S. STOCKS Apple, Hershey, Dow

BUZZ-U.S. STOCKS ON THE MOVE-Apple, Hershey, Dow Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes fell on Wednesday as worries of a less dovish Federal Reserve lifted Treasury yields, pressuring megacap stocks and amplifying losses in McDonald's and Coca-Cola shares.
A
A
B
N
N
Q
S
T
W
C
T
U
U
D
T
A
A

U.S. STOCKS Magnite, Nvidia, Tesla

BUZZ-U.S. STOCKS ON THE MOVE-Magnite, Nvidia, Tesla Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes moved lower on Wednesday, as worries of a less dovish Federal Reserve lifted Treasury yields, while losses in McDonald's and Coca-Cola also weighed on investors' minds.
A
B
I
N
N
Q
S
S
T
W
C
T
U
U
T
A
A
P

Thermo Fisher Says China Government's Stimulus And Loan Programs Affects The Industry In A Positive Way

BRIEF-Thermo Fisher Says China Government's Stimulus And Loan Programs Affects The Industry In A Positive Way Oct 23 (Reuters) - Thermo Fisher Scientific Inc TMO.N : THERMO FISHER EXEC SAYS COMPANY IS WELL-POSITIONED TO CAPITALIZE ON THE MARKET OPPORTUNITIES IN CHINA WHEN THE ECONOMY PICKS UP IN THE COUNTRY - CONF CALL THERMO FISHER EXEC SAYS CHINA
T

Thermo Fisher Scientific Inc reports results for the quarter ended in September 30 - Earnings Summary

Thermo Fisher Scientific Inc reports results for the quarter ended in September 30 - Earnings Summary Thermo Fisher Scientific Inc TMO.N reported quarterly adjusted earnings of $5.28​​ per share for the quarter ended September 30, lower than the same quarter last year, when the company reported EPS of $5.69. The mean expectation of twenty four analysts for the quarter was for earnings of $5.25 per share.
T

U.S. STOCKS Coca-Cola, Spirit Airlines, Boeing

BUZZ-U.S. STOCKS ON THE MOVE-Coca-Cola, Spirit Airlines, Boeing Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stock index futures signaled another lower open on Wednesday as Treasury yields ticked up, fueled by concerns of a potentially less dovish central bank, while investors focused on earnings from companies including Coca-Cola and Starbucks.
A
B
I
Q
S
C
T
U
T
A
A

Thermo Fisher falls after Q3 revenue miss

BUZZ-Thermo Fisher falls after Q3 revenue miss ** Life sciences firm Thermo Fisher Scientific's TMO.N shares fall 2.1% to $574 premarket ** Company's Q3 revenue of $10.60 bln misses est of $10.64 bln - LSEG ** TMO forecasts annual adj profit between $21.35 and $22.07 per share, midpoint of which is slightly below est of $21.72 ** Company reports qu
T

Thermo Fisher raises profit forecast on strong demand for its tools and services

Thermo Fisher raises profit forecast on strong demand for its tools and services Oct 23 (Reuters) - Thermo Fisher Scientific TMO.N on Wednesday raised the lower end of its annual profit forecast, tweaking it for the third time this year, betting on improved demand for its tools and services used in drug development. Contract drug manufacturers witnessed reduced spending from biotech clients last year, but recent interest cuts could improve the funding environment for biotechs as borrowing costs
T

Dollar rides rising yields, Canada set to ease

MORNING BID AMERICAS-Dollar rides rising yields, Canada set to ease A look at the day ahead in U.S. and global markets from Mike Dolan The dollar continues to ride higher on the back of an anxious pre-election climb in U.S. Treasury yields, notching its best levels in almost three months against the euro and yen on starkly contrasting economic and interest rate pictures.
A
B
E
I
M
N
T
U
L
L
J
U
U
U
T
A
U

Thermo Fisher Q3 Adjusted EPS USD 5.28 Vs. IBES Estimate USD 5.25

BRIEF-Thermo Fisher Q3 Adjusted EPS USD 5.28 Vs. IBES Estimate USD 5.25 Oct 23 (Reuters) - Thermo Fisher Q3 EPS USD 4.25. Q3 adjusted net income USD 2,026 million vs. IBES estimate USD 2,007 million Q3 adjusted EBIT USD 2,362 million vs. IBES estimate USD 2,370 million Q3 revenue USD 10,598 million vs. IBES estimate USD 10,638 million outlook FY ad
T

What to Watch in the Day Ahead - Wednesday, October 23

What to Watch in the Day Ahead - Wednesday, October 23 The Day Ahead is an email and PDF publication that includes the day's major stories and events, analyses and other features. To receive The Day Ahead, Eikon users can register at DAY/US . Thomson One users can register at RT/DAY/US. All times in ET/GMT Wall Street expects Tesla to post a 9% rise in quarterly revenue when the electric vehicle maker reports third-quarter results.
A
B
C
C
D
M
R
T
U
C
T
S
T
R

Thermo Fisher Scientific Inc <TMO.N> expected to post earnings of $5.25 a share - Earnings Preview

Thermo Fisher Scientific Inc expected to post earnings of $5.25 a share - Earnings Preview Thermo Fisher Scientific Inc TMO.N , TMO is expected to show a rise in quarterly revenue when it reports results on October 23 for the period ending September 30 2024 The Waltham Massachusetts-based company is expected to report a 0.6% increase in revenue to $10.638 billion from $10.57 billion a year ago, according to the mean estimate from 21 analysts, based on LSEG data.
T

US FDA Approves Based Companion Diagnostic For First Targeted Therapy For Patients With Grade 2 Mutant Glioma

BRIEF-US FDA Approves NGS-Based Companion Diagnostic For First Targeted Therapy For Patients With Grade 2 IDH-Mutant Glioma Oct 21 (Reuters) - Thermo Fisher Scientific Inc TMO.N : THERMO FISHER SCIENTIFIC: FDA APPROVES NGS-BASED COMPANION DIAGNOSTIC FOR FIRST TARGETED THERAPY FOR PATIENTS WITH GRADE 2 IDH-MUTANT GLIOMA Source text for Eikon: ID:nBw
T

U.S. STOCKS Avery Dennison, Snap-On, Avadel Pharma

BUZZ-U.S. STOCKS ON THE MOVE-Avery Dennison, Snap-On, Avadel Pharma Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street gained on Thursday, with the S&P 500 and the Dow touching intraday record highs, driven by TSMC's upbeat forecast and a bigger-than-expected rise in monthly retail sales indicating a strong U.S.
A
B
C
E
I
N
N
R
S
S
S
U
U
U
U
T
U
W
W
A
E
M
S

U.S. STOCKS PPG Industries, Travelers, ShiftPixy

BUZZ-U.S. STOCKS ON THE MOVE-PPG Industries, Travelers, ShiftPixy Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stock indexes were set to rise on Thursday, with an upbeat forecast from TSMC boosting semiconductor stocks, while a bigger-than-expected rise in September retail sales pointed to a strong U.S.
A
A
B
C
C
E
I
N
R
S
U
U
S
T
U
W
W
P
R

US life sciences firms get lift from Sartorius' results

BUZZ-US life sciences firms get lift from Sartorius' results ** Shares of US life sciences firms rise after German peer Sartorius's SATG.DE better-than-expected bioprocessing order intake in its nine-month results ** Premarket, Danaher DHR.N up 3.4%, Thermo Fisher Scientific TMO.N up 2.1% and Waters WAT.N up 1.7% ** Sartorius' order intake rose 6.6
T
W

U.S. STOCKS Wave Life Sciences, Dominion Energy, Voyager Therapeutics

BUZZ-U.S. STOCKS ON THE MOVE-Wave Life Sciences, Dominion Energy, Voyager Therapeutics Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The S&P 500 and the Nasdaq were little changed on Wednesday, with declines in heavily weighted technology megacaps limiting gains as investors turned to small-cap and financial stocks after a slew of upbeat bank earnings.
A
A
I
J
S
U
U
G
T
W
A

U.S. STOCKS Wave Life Sciences, Dominion Energy, Voyager Therapeutics

BUZZ-U.S. STOCKS ON THE MOVE-Wave Life Sciences, Dominion Energy, Voyager Therapeutics The Dow regained some lost ground on Wednesday although the S&P 500 and the Nasdaq stumbled, dragged lower by declines in megacap technology stocks, while the broader market gained from upbeat quarterly earnings from banks, notably Morgan Stanley. .N At 11:32 ET, the Dow Jones Industrial Average .DJI was up 0.4% to 42,924.64 at 11:34, pares gain.
A
A
C
D
I
S
J
U
U
U
G
T
W
A

Bernstein expects a 'not so scary' Q3 for US life sciences firms

BUZZ-Bernstein expects a 'not so scary' Q3 for US life sciences firms ** Brokerage Bernstein expects a "not so scary" Q3 earnings season for U.S. life sciences and tools firms, which "would be a real treat" for investors ** "With the recovery timeline for life science tools continuing to push out (further), some investors feel like they have been t
A
I
T
W

Thermo Fisher's plant making infant RSV drug breached FDA rules, documents show

EXCLUSIVE-Thermo Fisher's plant making infant RSV drug breached FDA rules, documents show Thermo Fisher's Greenville, N.C. plant has been found in breach of US FDA regulations, including twice this year FDA's most recent inspection of Thermo Fisher plant found shortfalls in manufacturing of Sanofi's and AstraZeneca's Beyfortus RSV treatment Sanofi says the FDA findings were addressed and all Beyfortus doses were approved by FDA before they were shipped Adds graphic By Patrick Wingrove Oct 4 (Reu
A
S
T



商品详情

热门商品

免责声明: XM Group仅提供在线交易平台的执行服务和访问权限,并允许个人查看和/或使用网站或网站所提供的内容,但无意进行任何更改或扩展,也不会更改或扩展其服务和访问权限。所有访问和使用权限,将受下列条款与条例约束:(i) 条款与条例;(ii) 风险提示;以及(iii) 完整免责声明。请注意,网站所提供的所有讯息,仅限一般资讯用途。此外,XM所有在线交易平台的内容并不构成,也不能被用于任何未经授权的金融市场交易邀约和/或邀请。金融市场交易对于您的投资资本含有重大风险。

所有在线交易平台所发布的资料,仅适用于教育/资讯类用途,不包含也不应被视为用于金融、投资税或交易相关咨询和建议,或是交易价格纪录,或是任何金融商品或非应邀途径的金融相关优惠的交易邀约或邀请。

本网站上由XM和第三方供应商所提供的所有内容,包括意见、新闻、研究、分析、价格、其他资讯和第三方网站链接,皆保持不变,并作为一般市场评论所提供,而非投资性建议。所有在线交易平台所发布的资料,仅适用于教育/资讯类用途,不包含也不应被视为适用于金融、投资税或交易相关咨询和建议,或是交易价格纪录,或是任何金融商品或非应邀途径的金融相关优惠的交易邀约或邀请。请确保您已阅读并完全理解,XM非独立投资研究提示和风险提示相关资讯,更多详情请点击 这里

风险提示: 您的资金存在风险。杠杆商品并不适合所有客户。请详细阅读我们的风险声明